psychotic episode
Item
a first episode of a psychotic illness is occurring or did occur within the last 2 years;
boolean
C0338614 (UMLS CUI [1])
dsm-iv schizophrenia schizoaffective disorder Depressive disorder
Item
a diagnosis by dsm-iv of schizophrenia, schizoaffective disorder, depressed type, or schizophreniform disorder; and
boolean
C0220952 (UMLS CUI [1,1])
C0036341 (UMLS CUI [1,2])
C0036337 (UMLS CUI [1,3])
C0011581 (UMLS CUI [1,4])
age
Item
between 18 and 45 years of age.
boolean
C0001779 (UMLS CUI [1])
exclusion criteria
Item
exclusion criteria (identical to clinical trial "parent study"):
boolean
C0680251 (UMLS CUI [1])
neurological disorder epilepsy; head injury
Item
neurological disorder (e.g., epilepsy) or significant head injury;
boolean
C0027765 (UMLS CUI [1,1])
C0014544 (UMLS CUI [1,2])
C0018674 (UMLS CUI [2])
Substance Use Disorder; psychotic episode
Item
significant alcohol or substance use disorder within the six months prior to the first episode and evidence that substance abuse triggered the psychotic episode or makes the schizophrenia diagnosis ambiguous;
boolean
C0038586 (UMLS CUI [1])
C0338614 (UMLS CUI [2])
mental retardation
Item
mental retardation, i.e. premorbid iq less than 70;
boolean
C0025362 (UMLS CUI [1])
english speaking; Speech and language disorder
Item
insufficient acculturation and fluency in the english language to avoid invalidating research measures of thought, language, and speech disorder or of verbal abilities;
boolean
C0376245 (UMLS CUI [1])
C0023009 (UMLS CUI [2])
residence
Item
residence likely to be outside of commuting distance of the ucla aftercare research program; or
boolean
C0237096 (UMLS CUI [1])
treatment resistant risperidone paliperidone paliperidone palmitate
Item
patient has shown an inadequate response to an adequate previous trial of oral or long-acting injectable risperidone, paliperidone, or paliperidone palmitate.
boolean
C4020575 (UMLS CUI [1,1])
C0073393 (UMLS CUI [1,2])
C0753678 (UMLS CUI [1,3])
C2719626 (UMLS CUI [1,4])